Pneumocystis pneumonia associated with human immunodeficiency virus

RF Miller, L Huang, PD Walzer - Clinics in chest medicine, 2013 - chestmed.theclinics.com
Different species of the ascomycetous yeastlike fungus Pneumocystis asymptomatically
infect/colonize numerous healthy mammalian hosts and in immune-compromised mammals …

The impact of cytomegalovirus infection on clinical severity and outcomes in kidney transplant recipients with Pneumocystis jirovecii pneumonia

S Lee, Y Park, SG Kim, EJ Ko… - Microbiology and …, 2020 - Wiley Online Library
Cytomegalovirus (CMV) infection is associated with Pneumocystis jirovecii pneumonia (PJP)
in kidney transplant recipients (KTRs), but its impact on clinical severity and outcomes in …

[HTML][HTML] Therapy and prophylaxis of opportunistic infections in HIV-infected patients: a guideline by the German and Austrian AIDS societies (DAIG/ÖAG)(AWMF 055 …

J Thoden, A Potthoff, JR Bogner, NH Brockmeyer… - Infection, 2013 - Springer
Introduction There was a growing need for practical guidelines for the most common OIs in
Germany and Austria under consideration of the local epidemiological conditions. Materials …

[HTML][HTML] Efficacy of trimethoprim–sulfamethoxazole in combination with an echinocandin as a first-line treatment option for Pneumocystis pneumonia: a systematic …

H Kato, M Hagihara, N Asai, T Umemura, Y Shibata… - Antibiotics, 2022 - mdpi.com
Although combination therapy using trimethoprim–sulfamethoxazole (TMP–SMX) plus
echinocandins has been reported to reduce the mortality of patients with pneumocystis …

Estimation of treatment and prognostic factors of pneumocystis pneumonia in patients with connective tissue diseases

Y Ishikawa, K Nakano, K Tokutsu, H Miyata, Y Fujino… - RMD open, 2021 - rmdopen.bmj.com
Objectives To investigate short-term prognosis and prognostic factors for connective tissue
disease-associated pneumocystis pneumonia (CTD-PCP) using the Japanese nationwide …

An official ATS workshop report: Emerging issues and current controversies in HIV-associated pulmonary diseases

A Morris, K Crothers, JM Beck… - Proceedings of the …, 2011 - atsjournals.org
Pulmonary diseases are major causes of morbidity and death in persons with HIV infection.
Millions of people with HIV/AIDS throughout the world are at risk of opportunistic …

[HTML][HTML] High initial (1, 3) Beta-d-Glucan concentration may be a predictor of satisfactory response of c aspofungin combined with TMP/SMZ for HIV-negative patients …

F Jin, X Liu, W Chen, Z Fan, H Wang - International Journal of Infectious …, 2019 - Elsevier
Objectives The aim of this study was to investigate the efficacy of combination therapy of
caspofungin and TMP/SMZ (trimethoprim/sulfamethoxazole) in moderate to severe …

Caspofungin combined with TMP/SMZ as a first‐line therapy for moderate‐to‐severe PCP in patients with human immunodeficiency virus infection

Q Tian, J Si, F Jiang, R Xu, B Wei, B Huang, Q Li… - HIV …, 2021 - Wiley Online Library
Objectives The effectiveness of trimethoprim/sulfamethoxazole (TMP/SMZ) for pneumocystis
pneumonia (PCP) is limited with adverse events. Caspofungin, by inhibiting the cyst form of …

Pneumocystis jirovecii pneumonia in systemic lupus erythematosus from southern Taiwan

CT Weng, MF Liu, MY Weng, NY Lee… - JCR: Journal of …, 2013 - journals.lww.com
Background Opportunistic infection has been documented in systemic lupus erythematosus
with special attention paid to Pneumocystis jirovecii because of the significant morbidity and …

[HTML][HTML] Chloroquine binding reveals flavin redox switch function of quinone reductase 2

KKK Leung, BH Shilton - Journal of Biological Chemistry, 2013 - ASBMB
Quinone reductase 2 (NQO2) is an FAD-linked enzyme and the only known human target of
two antimalarial drugs, primaquine (PQ) and chloroquine (CQ). The structural differences …